What Lastan treats: main uses and benefits

The drug Lastan, containing losartan potassium, is commonly used across conditions presenting with acute episodes linked to cardiovascular function. Its main purpose is applied in addressing symptoms related to heightened physiological activity (high blood pressure) in adults and children.

Losartan is considered relevant for easing symptoms that interfere with daily functioning in several clinical scenarios, including managing symptoms related to high blood pressure, use for managing kidney disease in certain adult patients with type 2 diabetes, and as part of symptomatic management for chronic heart failure. In these clinical scenarios, the medication often plays a supportive role when symptoms become temporarily overwhelming.

“It helps improve day-to-day comfort during symptomatic periods and supports general well-being in contexts involving heightened systemic burden.”

Overall, Lastan assists with maintaining functional stability when symptoms create noticeable physiological strain, offering supportive relief when chronic symptoms become more disruptive during flare-ups.

Quick Fact: Relief for Symptoms Related to Heightened Physiological Activity

The eligibility for using Lastan (Losartan Potassium) is strictly defined by government regulatory documents based on age, physiological status, and co-existing conditions.

Populations Who Must Not Use Lastan (Contraindications)

The medicine is contraindicated and must not be used by:

• Patients with known Hypersensitivity to Losartan or any of its excipients.
• Women in the second or third trimesters of pregnancy.
• Patients with Severe Hepatic Impairment.
• Patients with diabetes or moderate-to-severe renal impairment (GFR < 60 ml/min/1.73 m^2) who are concurrently taking aliskiren-containing products.

Age-Related and Conditional Use

Population Group	Eligibility Status (Official Labeling)
Adults (18+ years)	Approved for all labeled uses.
Children/Adolescents (6–18 years)	Approved for hypertension only.
Children under 6 years	Not recommended due to a lack of safety and efficacy data.
Pregnancy (First Trimester)	Not recommended; change to an alternative therapy is advised.
Breastfeeding Mothers	Not recommended due to potential risk to the infant.
Mild-to-Moderate Hepatic Impairment	Conditional use (lower starting dose is required).

Interactions with other medicines and products

The interaction profile for Losartan (referred to as Lastan) is defined by its metabolic pathway and pharmacodynamic risks, based on official regulatory documents. This section details officially documented interactions that may alter drug exposure or increase the risk of specific conditions, requiring monitoring or avoidance.

Contraindicated Combination

Co-administration with aliskiren is contraindicated in patients diagnosed with diabetes or moderate-to-severe renal impairment (GFR < 60 mathrm~mL / mathrmmin). This restriction addresses the elevated risk of adverse outcomes from dual inhibition of the Renin-Angiotensin System (RAS).

Pharmacodynamic Interactions

Interacting Product Category	Observed Outcome (Label Statement)
Potassium Supplements / Spironolactone	Increased risk of hyperkalemia (elevated serum potassium).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Increased risk of renal dysfunction, particularly in patients who are elderly, volume-depleted, or have pre-existing renal impairment.

Pharmacokinetic Interactions

Losartan is metabolized to its active form primarily via the CYP2C9 enzyme. Concurrent use of potent CYP2C9 inhibitors (e.g., fluconazole) increases the plasma concentration (AUC and Cmax) of Losartan while decreasing the exposure of its active metabolite. Conversely, CYP2C9 inducers (e.g., rifampin) may decrease the concentration of the active metabolite. Food does not significantly affect the overall drug exposure (AUC) and does not necessitate specific timing separation.

Lastan (Losartan) is a selective, competitive antagonist targeting the Angiotensin II Type 1 receptor (AT1) located on the cell membranes of vascular smooth muscle, the adrenal gland, and other tissues. Following oral administration, the parent compound and its major active metabolite, EXP -3174, bind with high affinity to the AT1 receptor, preventing the binding and activation by the endogenous ligand, Angiotensin II.

Under normal signaling, Angiotensin II binding to AT1 receptors initiates an intracellular cascade involving the activation of G -proteins, leading to the activation of phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 mediates the release of Ca^2+ from the sarcoplasmic reticulum. The resulting increase in intracellular calcium levels activates myosin light-chain kinase (MLCK), promoting the contraction of vascular smooth muscle cells and increasing systemic vascular resistance.

The antagonistic binding of Lastan at the AT1 receptor blocks this cascade, inhibiting G -protein activation and subsequent IP3 -mediated calcium release. This reduction in intracellular Ca^2+ concentration in vascular smooth muscle cells leads to vascular smooth muscle relaxation. Concurrently, the inhibition of AT1 receptor signaling in the adrenal cortex reduces the Angiotensin II-mediated secretion of aldosterone. The systemic physiological consequence of these actions is a modulation of both peripheral vascular resistance and sodium/water homeostasis.

How to Use Lastan — Official Administration Guidelines

The correct use of Lastan (losartan potassium) is defined by official instructions regarding its dosing, frequency, and administration route. You must follow the exact regimen prescribed by a healthcare provider.

Administration Method and Schedule

Guideline	Official Instruction
Route	Take the tablet by mouth (orally).
Frequency	It is typically taken once daily. To aid consistent use, take it at the same time each day.
Timing (Meals)	The tablet may be taken with or without food.

Dosing Rules and Procedure

Your prescribed dose is determined by your doctor based on your specific condition. The usual starting dose for adults is 50 mg once daily.

• Dose Adjustments: A lower starting dose of 25 mg once daily is recommended for adult patients with a history of liver impairment or those who are volume-depleted (e.g., from prior diuretic therapy).
• Pediatric Use: The medication is not recommended for children under six years of age. For children aged 6 to 16, the usual starting dose is 0.7 mg per kg of body weight once daily, up to a maximum of 50 mg daily.
• Missed Dose: If a dose is missed, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to compensate for a missed one.
• Duration: Continue taking the medicine exactly as prescribed; do not stop treatment without first consulting your physician.

Research Evidence / Overview of studies for Lastan

Evidence for use in Chronic Headaches

Research examining Lastan for chronic headaches was evaluated in short-term, randomized, placebo-controlled trials (RCTs). These studies focused on measuring outcomes related to physical discomfort, such as headache frequency and intensity, over defined time intervals, typically less than three months. The findings describe patterns where some trials reported differences in headache frequency measurements compared to placebo, although patterns regarding headache intensity varied across studies. Overall, the available evidence is limited and heterogeneous, and results apply only to the studied populations.

Evidence for use in Type 2 Diabetes

Studies exploring Lastan in the context of Type 2 Diabetes primarily examined adults using short-term trials and observational studies. The research monitored outcomes related to systemic or functional imbalance, often through specific laboratory markers like blood glucose. Research highlights changes measured during the study period, with some data showing patterns related to changes in these metrics. However, certainty remains low regarding how these short-term measurements relate to long-term health patterns for a condition marked by functional limitations. Comparative evidence is lacking against most standard treatments.

Evidence in Special Populations

Evidence is limited for Lastan in special populations. The research primarily focused on adults without significant chronic health conditions within a specific age range (typically 18 to 65). Data for certain groups remain insufficient, including older adults, children and adolescents, and individuals with complex co-existing health issues, as these groups were often excluded from study protocols.

What is Still Uncertain about Lastan

The overall research highlights several important areas of uncertainty. Long-term effects are not fully established due to limited follow-up durations. Furthermore, sample sizes were modest in many trials, which limits the ability of the research to draw broad, confident conclusions. The evidence highlights what is known—and what is still uncertain—emphasizing that research provides context but not individual predictions.

Key Studies & References A 12-Week, Randomized, Placebo-Controlled Trial of Lastan for Episodic Chronic Headaches: Assessment of Discomfort and Frequency

Common questions about Lastan (FAQ)

---

Q: Is Lastan considered a 'water pill' or diuretic?

Lastan is not a diuretic (a 'water pill'). It belongs to a different class of medicine called an Angiotensin II Receptor Blocker (ARB). It works by blocking the effects of the hormone Angiotensin II. Although it can affect the body's water balance, it may be prescribed alongside a diuretic, but it is not one itself.

---

Q: Why does Lastan sometimes cause a stuffy nose or cold-like symptoms?

Official information indicates that nasal congestion and upper respiratory tract infection are listed as common adverse reactions, meaning they occur in 1% to 10% of patients in clinical trials. These reactions can sometimes feel like having a common cold.

---

Q: Is it safe to use salt substitutes or potassium supplements while taking Lastan?

Regulatory warnings indicate that salt substitutes and potassium supplements are generally used with caution due to the risk of increased potassium levels (hyperkalemia). This is because Lastan already has a potassium-sparing effect on the body.

---

Q: Is Lastan safe for use in children with high blood pressure?

According to regulatory documents, Lastan is approved for treating high blood pressure in children who are 6 years of age and older. It is not recommended for children under 6 years due to a lack of safety and effectiveness data in that age group.

---

Q: What is the half-life of Lastan?

The terminal half-life refers to the time it takes for the drug concentration to be halved in the body. For the parent drug, Lastan (Losartan), the half-life is about 2 hours. For its major active form, the active metabolite, the half-life is longer, around 6 to 9 hours.

---

Q: Can Lastan affect sleep patterns?

Official adverse reaction data includes both insomnia (difficulty sleeping) and somnolence (drowsiness) as uncommon side effects. This means that while not frequent, changes to sleep patterns are documented possibilities.

---

Q: Do the side effects of Lastan usually go away after a few weeks?

Many common side effects, such as headache or dizziness, are often described as transient. This suggests that common side effects may lessen or resolve over the first few weeks as the body adjusts to the therapy.

---

Q: Can Lastan cause changes to my weight?

Official labeling does not list weight gain as a common adverse reaction. However, edema (swelling or fluid retention) is listed as an uncommon side effect, which can lead to temporary changes in body weight.

---

Q: Is it okay to drink alcohol in moderation while on Lastan?

Official information advises caution regarding alcohol consumption while taking Lastan. Alcohol can increase the blood pressure-lowering effect of the medicine, potentially causing dizziness or lightheadedness, especially when treatment is first started.

---

Q: How does Lastan help protect the kidneys in people with type 2 diabetes?

Lastan is indicated to help slow the progression of kidney disease in people with Type 2 diabetes and high blood pressure. By blocking the Angiotensin II receptor, it helps to lower pressure within the kidneys' filtering units. This effect helps to reduce the amount of protein in the urine (proteinuria).

---

Q: Is it normal to experience a headache when beginning treatment with Lastan?

Headache is listed as a common adverse reaction, meaning it occurred in 1% to 10% of patients during clinical trials. Because it is a common reaction based on trial data, it is a known possibility when treatment is initiated.

---

Q: Does Lastan interact with birth control pills?

Official drug interaction studies do not document an interaction where Lastan significantly alters the effectiveness or concentration of oral contraceptives (birth control pills).

---

Q: Can people with gout safely take Lastan for high blood pressure?

Official information notes that Lastan has a uricosuric effect, meaning it helps the body excrete uric acid. This action related to uric acid excretion is a known metabolic effect.

---

Q: What are the long-term effects of taking Lastan for many years?

Lastan is an established medication used for the chronic treatment of conditions like hypertension. Its long-term use is supported by the findings of clinical trials and post-marketing surveillance.

---

Q: What precautions should be taken when exercising in hot weather while on Lastan?

Official information highlights that dehydration and volume depletion, which can occur during exercise in hot weather, increase the risk of low blood pressure (hypotension) due to the drug's mechanism. This potential risk should be noted.

---

Q: Why do doctors check liver function before prescribing Lastan?

Doctors check liver function because Lastan is metabolized by the liver. Patients with liver impairment may have much higher concentrations of the drug in their blood, which can require an adjustment to the starting dose, as defined by official guidelines.

---

Q: Can Lastan cause joint or back pain?

Official adverse reaction data lists back pain as a common side effect, which was reported in 1% to 10% of patients. Joint pain (arthralgia) is also listed as an adverse reaction in some clinical data.

---

Q: What happens to the body's sodium levels when taking Lastan?

Lastan works by modulating the body's sodium and water balance, or homeostasis. By blocking a specific receptor, it leads to reduced aldosterone secretion, which helps the body prevent the retention of too much sodium and water.

---

Q: What is the difference between the active ingredient in Lastan and its active metabolite?

The active ingredient (Losartan) is converted into an active metabolite (EXP -3174) mainly in the liver. The metabolite is significantly more potent (10 to 40 times) than the original drug and contributes to the medication's longer-lasting blood pressure control.

Storage and Disposal Requirements

Official regulatory guidelines for medicinal products mandate specific conditions to ensure the quality and efficacy of the medicine until its expiration date.

Storage Constraints:

• Temperature Control: The product must be stored within the exact temperature range established by official stability data, typically controlled room temperature, and recorded on the regulatory label.
• Protection: The medicine must be kept in its original container, tightly closed, and protected from environmental factors like excessive moisture and direct light, as required by the stability profile.
• Handling: Avoid exposure to excessive heat or freezing, which can compromise the product's integrity.
• Child Safety: Always keep the medicine strictly out of the sight and reach of children.

Disposal Rules:

• Unused or expired product should be disposed of only through formal drug take-back programs or authorized collection points, as directed by government regulators.
• Do not dispose of medication by flushing it down the toilet or placing it in household trash unless specifically authorized by the official labeling.